# Adma Biologics, Inc.: Form 8-K, filed Jun 4, 2024

- Company: [Adma Biologics, Inc.](/companies/adma.md) (CIK 1368514)
- Form: 8-K
- Filed: 2024-06-04
- Accepted by EDGAR: Jun 4, 2024, 16:05 ET
- Period: 2024-06-04
- Accession: 0001140361-24-028800
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/ef20030555_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/ef20030555_8k.htm

Filed Jun 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-028800. Last ingested by Listed: Nov 6, 2026, 02:03 ET. No prices; not investment advice.